Russell Investments Group Ltd. Purchases 12,174 Shares of Solventum Co. (NYSE:SOLV)

Russell Investments Group Ltd. lifted its holdings in Solventum Co. (NYSE:SOLV - Free Report) by 29.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,491 shares of the company's stock after acquiring an additional 12,174 shares during the quarter. Russell Investments Group Ltd.'s holdings in Solventum were worth $3,534,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Modus Advisors LLC acquired a new position in shares of Solventum during the fourth quarter worth approximately $25,000. Stonebridge Financial Group LLC acquired a new position in Solventum during the 4th quarter worth $26,000. Crews Bank & Trust acquired a new position in Solventum during the 4th quarter worth $32,000. Synergy Asset Management LLC bought a new position in Solventum in the 4th quarter valued at $35,000. Finally, Spire Wealth Management bought a new stake in shares of Solventum during the fourth quarter worth approximately $37,000.

Analysts Set New Price Targets

SOLV has been the subject of several recent research reports. Mizuho upped their target price on shares of Solventum from $70.00 to $82.00 and gave the company a "neutral" rating in a research report on Monday, March 3rd. Wells Fargo & Company increased their target price on Solventum from $73.00 to $75.00 and gave the company an "equal weight" rating in a research note on Friday, February 28th. Morgan Stanley upped their price target on Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a research note on Wednesday, March 5th. Piper Sandler upped their target price on shares of Solventum from $75.00 to $84.00 and gave the company a "neutral" rating in a research note on Friday, February 28th. Finally, Bank of America lifted their price target on shares of Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $79.86.

Solventum Stock Up 1.7 %

Shares of SOLV stock traded up $1.08 during trading hours on Tuesday, hitting $65.02. 609,910 shares of the company were exchanged, compared to its average volume of 1,317,117. The company has a market capitalization of $11.25 billion and a PE ratio of 23.64. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $85.92. The business has a 50 day moving average of $73.04 and a two-hundred day moving average of $71.60. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.